Financhill
Back

NeuroBo Pharmaceuticals Quote, Financials, Valuation and Earnings

NeuroBo Pharmaceuticals Price Quote

$2.35
-0.05 (-2.08%)
(Updated: November 21, 2024 at 5:55 PM ET)

NeuroBo Pharmaceuticals Key Stats

Sell
22
NeuroBo Pharmaceuticals (NRBO) is a Sell

Day range:
$2.30 - $2.50
52-week range:
$2.08 - $6.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.54%

Volume:
20.7K
Avg. volume:
38.6K
1-year change:
-31.08%
Market cap:
$19.9M
Revenue:
$0
EPS:
$-4.77

How Much Does NeuroBo Pharmaceuticals Make?

Data Unavailable

Is NeuroBo Pharmaceuticals Growing As A Company?

Data Unavailable

NeuroBo Pharmaceuticals Stock Price Performance

What Is NeuroBo Pharmaceuticals 52-Week High & Low?

NeuroBo Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy NeuroBo Pharmaceuticals?

Is NeuroBo Pharmaceuticals Cash Flow Positive?

  • What Is NRBO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$22.7M
  • What Is NeuroBo Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $18.5M
  • What Is NeuroBo Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$17K

NeuroBo Pharmaceuticals Return On Invested Capital

Data Unavailable

NeuroBo Pharmaceuticals Earnings Date & Stock Price

NeuroBo Pharmaceuticals Competitors

NeuroBo Pharmaceuticals Dividend Yield

NeuroBo Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 26.67
Upside from Last Price: 1011.11%

Major Shareholders

  • How many NRBO shares are owned by institutional investors?
    12.8M NRBO shares are owned by institutional investors
  • How many NRBO shares are owned by insiders?
    4M NRBO shares are owned by insiders